Evidence-based guideline: Antiepileptic drug selection for people with HIV/AIDSGretchen L. Birbeck, René H. Levy, Jacqueline A. French et al.|Neurology|2012Cited by 91
Characteristics and outcomes of KSHV-associated multicentric Castleman disease with or without other KSHV diseasesRamya Ramaswami, Robert Yarchoan, Richard F. Little et al.|Blood Advances|2021Cited by 78
Use of pembrolizumab with or without pomalidomide in HIV-associated non-Hodgkin’s lymphomaKathryn Lurain, Robert Yarchoan, Ramya Ramaswami et al.|Journal for ImmunoTherapy of Cancer|2021Cited by 69
Antiepileptic drug selection for people with HIV/AIDS: Evidence‐based guidelines from the ILAE and AANGretchen L. Birbeck, Houda Hachad, Jacqueline A. French et al.|Epilepsia|2012Cited by 59
Treatment of HIV-associated primary CNS lymphoma with antiretroviral therapy, rituximab, and high-dose methotrexateKathryn Lurain, Robert Yarchoan, Thomas S. Uldrick et al.|Blood|2020Cited by 45